MacroGenics
MGNX
#9382
Rank
โ‚น8.01 B
Marketcap
โ‚น126.76
Share price
-0.71%
Change (1 day)
-53.29%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.53. In 2024 the company made an earnings per share (EPS) of -โ‚น96.88 a decrease over its 2023 EPS that were of -โ‚น13.58.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.86%
2024-โ‚น96.88613.33%
2023-โ‚น13.58-92.31%
2022-โ‚น176.56-42.14%
2021-โ‚น305.1336.44%
2020-โ‚น223.64-21.84%
2019-โ‚น286.12-24.58%
2018-โ‚น379.38675.93%
2017-โ‚น48.89-68.05%
2016-โ‚น153.02168.25%
2015-โ‚น57.04-55%
2014-โ‚น126.763400%
2013-โ‚น3.62-108.68%
2012โ‚น41.7424.49%
2011โ‚น33.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-โ‚น160.26 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.74-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น687.57-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น590.35-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,180-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,858-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น268.92-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA